ACTB and colorectal cancer: The Western blot results show that compounds 15o and 15r inhibited the expression levels of PI3K p85, β-actin, AXIN-2, TAB-182, and β-catenin proteins, as these markers are involved via the β-catenin pathway in colorectal cancer.